| 1 |
35422660 | Exenatide Once Weekly for Management of Type 2 Diabetes: A Review. | 2022 |
1 |
| 2 |
33043591 | Efficacy and safety of exenatide as add-on therapy for patients with type 2 diabetes with an intensive insulin regimen: A randomized double-blind trial. | 2021 Feb |
2 |
| 3 |
31518492 | Efficacy and safety of once-weekly exenatide after switching from twice-daily exenatide in patients with type 2 diabetes. | 2020 Mar |
1 |
| 4 |
29394878 | Real-world clinical responses in patients with type 2 diabetes mellitus adding exenatide BID (EBID) or mealtime insulin to basal insulin: a retrospective study using electronic medical record data. | 2018 Jun |
1 |
| 5 |
29397532 | Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes. | 2018 Apr |
1 |
| 6 |
28085521 | Exenatide: pharmacokinetics, clinical use, and future directions. | 2017 Apr |
7 |
| 7 |
29044860 | Effects of exenatide twice daily, exenatide once weekly or insulin in patients with type 2 diabetes and baseline HbA1c ≥10.0%: Two pooled analyses including 20 randomised controlled trials. | 2017 Dec |
1 |
| 8 |
31149215 | THE EFFECT OF EXENATIDE THERAPY IN PREVIOUSLY INSULIN-TREATED TYPE 2 DIABETIC PATIENTS. | 2017 Oct-Dec |
1 |
| 9 |
26706658 | Liraglutide Versus Exenatide Once Weekly: Persistence, Adherence, and Early Discontinuation. | 2016 Jan 1 |
4 |
| 10 |
26827116 | Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis. | 2016 Apr |
4 |
| 11 |
27356188 | The cost-effectiveness of exenatide twice daily (BID) vs insulin lispro three times daily (TID) as add-on therapy to titrated insulin glargine in patients with type 2 diabetes. | 2016 Dec |
5 |
| 12 |
27776251 | The effects of exenatide twice daily compared to insulin lispro added to basal insulin in Latin American patients with type 2 diabetes: A retrospective analysis of the 4B trial. | 2016 Dec |
8 |
| 13 |
25589020 | Clinical effectiveness of exenatide in diabetic patients waiting for bariatric surgery. | 2015 Mar |
1 |
| 14 |
26134916 | Cost-effectiveness analysis of exenatide twice daily (BID) vs insulin glargine once daily (QD) as add-on therapy in Chinese patients with Type 2 diabetes mellitus inadequately controlled by oral therapies. | 2015 |
2 |
| 15 |
24298995 | Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a prospective randomized open-label trial. | 2014 Jun |
1 |
| 16 |
24621255 | Addition of exenatide BID to insulin glargine: a post-hoc analysis of the effect on glycemia and weight across a range of insulin titration. | 2014 Jul |
7 |
| 17 |
25059703 | Retrospective cohort study evaluating exenatide twice daily and long-acting insulin analogs in a Veterans Health Administration population with type 2 diabetes. | 2014 Sep |
5 |
| 18 |
25326840 | [Twice-daily and weekly exenatide: Clinical profile of two pioneer formulations in incretin therapy]. | 2014 |
2 |
| 19 |
25437462 | [Twice-daily and weekly exenatide: clinical profile of two pioneer formulations in incretin therapy]. | 2014 Sep |
2 |
| 20 |
23473527 | Safety and efficacy of twice-daily exenatide in Taiwanese patients with inadequately controlled type 2 diabetes mellitus. | 2013 Mar |
2 |
| 21 |
23667315 | Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries. | 2013 |
3 |
| 22 |
23799930 | Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study. | 2013 Jun 22 |
4 |
| 23 |
23874113 | Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study. | 2013 |
4 |
| 24 |
23981106 | A pooled analysis of exenatide use and risk of acute pancreatitis. | 2013 Dec |
4 |
| 25 |
24186595 | Exenatide twice daily versus insulin glargine for the treatment of type 2 diabetes in Poland - subgroup data from a randomised multinational trial GWAA. | 2013 |
4 |
| 26 |
22236356 | Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment. | 2012 Jun |
3 |
| 27 |
22321776 | Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting. | 2012 Jul |
2 |
| 28 |
22443463 | Exenatide BID and liraglutide QD treatment patterns among type 2 diabetes patients in Germany. | 2012 |
4 |
| 29 |
22519390 | Metabolic outcomes of elderly patient populations initiating exenatide BID versus insulin glargine in an ambulatory care setting. | 2012 Jun |
2 |
| 30 |
22608106 | Long-term effects of adding exenatide to a regimen of metformin and/or sulfonylurea in type 2 diabetes: an uncontrolled, open-label trial in Hungary. | 2012 Jun |
4 |
| 31 |
22725703 | A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes. | 2012 Jul |
1 |
| 32 |
22913891 | Exenatide twice daily: analysis of effectiveness and safety data stratified by age, sex, race, duration of diabetes, and body mass index. | 2012 Jul |
4 |
| 33 |
21158486 | Healthcare resource utilization and costs assessment of type 2 diabetes patients initiating exenatide BID or glargine: a retrospective database analysis. | 2011 |
1 |
| 34 |
21219119 | Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting. | 2011 Mar |
2 |
| 35 |
21285388 | Exenatide twice daily versus premixed insulin aspart 70/30 in metformin-treated patients with type 2 diabetes: a randomized 26-week study on glycemic control and hypoglycemia. | 2011 Mar |
2 |
| 36 |
21410975 | Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes. | 2011 Mar 16 |
3 |
| 37 |
21892855 | Hypoglycemia in patients with type 2 diabetes using concomitant exenatide BID and long-acting insulin therapy. | 2011 |
2 |
| 38 |
22085180 | Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting. | 2011 Dec |
10 |
| 39 |
21437086 | Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus. | 2010 May 17 |
2 |
| 40 |
19573122 | Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily. | 2009 Jul |
1 |
| 41 |
18555933 | Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study. | 2008 May |
1 |